TELEHEALTH
1300 881 698
TELEHEALTH | 1300 881 698
New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers
Tamara Grigg
Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of
Advocating for upper GI cancers: oesophageal and gastric cancer update
An important part of Pancare supporting patients with upper gastrointestinal (GI) cancers is advocating for better treatment and unmet needs.